G. Balan

发表

Expedient synthesis of sulfinamides from sulfonyl chlorides.

Chaofeng Huang, Pinguan Zheng, M. Harmata, 2007, The Journal of organic chemistry.

Complementary α-alkylation approaches for a sterically hindered spiro[pyrazolopyranpiperidine]ketone

C. Limberakis, D. Kung, D. Griffith, 2012 .

Chemically-enabled synthesis of 1,2,3,4-tetrahydroisoquinolin-1-ones

Edward L. Conn, Yu Hui, Paul S. Humphries, 2009 .

Synthesis, Structure, and Biological Activity of Copper and Cobalt Coordination Compounds with Substituted 2-(2-Hydroxybenzylidene)-N-(prop-2-en-1-yl)hydrazinecarbothioamides

P. Petrenko, Y. Chumakov, V. Graur, 2019, Russian Journal of General Chemistry.

The discovery of novel calcium sensing receptor negative allosteric modulators.

J. Bauman, David A. Price, A. Kalgutkar, 2009, Bioorganic & medicinal chemistry letters.

Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core.

M. Munchhof, J. Litchfield, K. Karki, 2011, Bioorganic & medicinal chemistry letters.

The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH).

L. Chen, B. Cravatt, K. Zasadny, 2012, Nuclear medicine and biology.

Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.

W. Soeller, Edward L. Conn, Paul S. Humphries, 2009, Bioorganic & medicinal chemistry letters.

Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator.

J. Cianfrogna, A. Stepan, Daniel P. Walker, 2014, Journal of medicinal chemistry.

Metabolism-guided design of short-acting calcium-sensing receptor antagonists.

J. Bauman, David A. Price, A. Kalgutkar, 2010, ACS medicinal chemistry letters.

Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates.

J. Cianfrogna, A. Stepan, Daniel P. Walker, 2017, Journal of medicinal chemistry.

The discovery of novel calcium sensing receptor negative allosteric modulators.

J. Bauman, A. Kalgutkar, V. Paralkar, 2009, Bioorganic & medicinal chemistry letters.